Intellia Therapeutics, Inc. (NTLA)

13.60 -1.84 (-11.88%) USD  |  NASDAQ  |  Mar 03, 16:00
13.63 +0.02 (+0.18%) After-Hours: 20:00
More

Intellia Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Personalis, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Twist Bioscience Corp. Upgrade